|RBS Global Big Pharma ETN||
|The investment seeks to replicate, net of expenses, the NYSE Arca Equal Weighted Pharmaceutical Total Return Index.
The index is designed to track the performance of the equity securities of a cross section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts.|
| ||DRGS||Category Avg|
|Annual Report Expense Ratio (net)||N/A||N/A|
|Annual Holdings Turnover||N/A||N/A|
|Total Net Assets||NaN||N/A|